Publications
- Highlighted Item:
- Publisher:
- Publication Date:
- Reference:
- DOI:
- PMID:
- Publication Type:Presentation
- Scientific Area:
- Endpoint:
- Industry Type:
(Q)SAR Evaluation of Drug Impurities from the US FDA Scientific Perspective
This presentation was given by Dr Naomi Kruhlak, at the 2019 Pharmaceutical Industry and Regulators Symposium, in Brazil.